Covaxin has become the only Covid-19 vaccine in the world to have studied and generated data from trials on kids as young as two years. Results of the trial showed seroconversion at 95-98% in children of all age groups, four weeks after they received their second dose.
from Times of India https://ift.tt/3FMKQH5
via IFTTT
Thursday, December 30, 2021
Free Press Journal | World News
The Indian Express | World News
The Indian Express | Sports
Times of India | World News Headlines, Latest International News, World Breaking News
The Guardian | World News
Dash & Outdoor Cameras from Rexing
Search cheapest worldwide Flight/Hotel/Cruise/Car/Activities
Travel Insurance
0 comments:
Post a Comment